Spain· ES:60377
PROHANCE 279,3 mg/ml SOLUCION INYECTABLE
A medicinal product containing gadoteridol, registered in Spain by Bracco International B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- gadoteridol
- Manufacturer
- Bracco International B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gadoteridol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPROHANCEBracco Imaging Deutschland GmbH, Konstanz
- BelgiumProhance 279.3 mg/mlBracco Imaging Deutschland
- SwedenProHance 279,3 mg/ml Injektionsvätska, lösningBracco International BV
- PolandProHanceBracco Imaging Deutschland GmbH
- NetherlandsProHance, oplossing voor injectie 279,3 mg/ml = 0,5 molairBracco Imaging Deutschland GmbH
- NorwayProHanceBracco International B.V.
- SwitzerlandProHance 0.5 mmol/ml, soluzione iniettabile (flacone)Bracco Suisse SA
- United KingdomProHance 0.5mmol/ml solution for injection 10ml pre-filled syringesBracco UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Prohance
- Belgium · Prohance
- Czechia · Prohance
- Germany · Prohance
- Denmark · Prohance
- Estonia · Prohance
- Finland · Prohance
- France · Prohance
- United Kingdom (Northern Ireland) · Prohance
- Greece · Prohance
- Croatia · Prohance
- Hungary · Prohance
- Ireland · Prohance
- Italy · Prohance
- Lithuania · Prohance
- Luxembourg · Prohance
- Latvia · Prohance
- Netherlands · Prohance
- Norway · Prohance
- Poland · Prohance
- Portugal · Prohance
- Romania · Prohance
- Sweden · Prohance
- Slovenia · Prohance
- Slovakia · Prohance
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/17bc5478-dd2e-4cd9-ac51-28a357a94778 GET /v1/drugs/17bc5478-dd2e-4cd9-ac51-28a357a94778?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario Y Centros De Diagnóstico Autorizados",
"estado": "{\"aut\":912466800000}",
"nregistro": "60377",
"substance": "gadoteridol"
}See everything about gadoteridol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.